AstraZeneca PLC
Trump’s pharmaceutical tariff threat loses bite after Pfizer deal reassures drugmakers
U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with Pfizer to lower Medicaid drug prices in the Oval Office of the White House on September 30, 2025 in Washington, DC. Win Mcnamee | Getty Images President Donald Trump’s long-awaited threat to impose pharmaceutical tariffs may not […]
Read More
From Spain’s bull run to gold’s surge: How the third quarter played out in Europe
Spain’s IBEX equity index has posted a return of nearly 10% over the last few weeks, way above its continental peers. Source
Read More
UK PM Starmer prepares for critical address — and much is riding on what he says
British Prime Minister Keir Starmer touches his glasses during a press conference with U.S. President Donald Trump (not pictured) at the White House in Washington, D.C., U.S., Feb. 27, 2025. Brian Snyder | Reuters Seldom, if ever, can a British prime minister, barely a year into office and sitting on an enormous parliamentary majority, have […]
Read More
European stocks close higher as pharma giants AstraZeneca and GSK notch gains
Stocks listed in Europe closed higher on Monday, as investors monitored the impact of a potential U.S. government shutdown later in the week. The pan-European Stoxx 600 provisionally ended up around 0.34%, with most sectors and major bourses in positive territory. Lufthansa ended the session slightly higher, paring earlier gains, after it said its free […]
Read More
Why Trump’s 100% drug tariffs could hit Asia and Europe very differently
Global pharmaceutical stocks sold off on Friday, as markets reacted to news of 100% tariffs on branded and patented drugs imported into the United States, but significant moves lower haven’t been across the board. While Asia Pacific-listed shares in the sector saw notable falls — with some stocks tumbling more than 5% — the reaction […]
Read More
A world on weight loss drugs: How GLP-1s are reshaping the economy
Eternalcreative | Istock | Getty Images Miracle drugs, obesity treatments and skinny jabs. Call them what you will, few drugs have had a more transformative effect on Wall Street and waistlines over recent decades than GLP-1s. Familiarly known under the brand names Wegovy and Zepbound, Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medication used to […]
Read More
Eli Lilly’s obesity pill remains a viable rival to Novo’s oral Wegovy despite data that underwhelmed investors
A sign with the company logo sits outside of the headquarters of Eli Lilly in Indianapolis, Indiana, on March 17, 2024. Scott Olson | Getty Images Eli Lilly‘s stock is still recovering after the drugmaker released trial data earlier this month on its closely watched obesity pill that underwhelmed Wall Street. In a key late-stage trial, […]
Read More
Buy these outperforming stocks with room to run, says UBS
As earnings season winds down, investors should be on the lookout for some stocks that might still have room for upside, according to UBS. Stocks rallied on Friday , spurred by Federal Reserve Chair Jerome Powell’s comments in Jackson Hole, Wyo. that suggested the central bank may begin adjusting its policy stance . Even with […]
Read More
Eli Lilly’s 170% UK price hike for Mounjaro is just the start as pharma firms bow to Trump’s pricing pressures
Key Points Pharma giants are navigating U.S. President Donald Trump’s demands to bring U.S. drug prices in line with other developed nations. Eli Lilly’s decision to hike Mounjaro prices in the U.K. could spark similar moves from other firms, analysts say. The U.S. consistently pays the most in the world for many prescription drugs. Eli Lilly ‘s […]
Read More
London’s FTSE 100 just touched a record high — and market watchers see more upside ahead
London’s FTSE 100 touched a fresh record high on Friday – and some market watchers see more upside ahead for the long-maligned index, with U.S. tariffs, macroeconomic influences and outperformance in certain sectors sparking a widespread reassessment of U.K. equities. The U.K. index — home to some of the world’s most renowned companies, including AstraZeneca […]
Read More